Navigation Links
New England Biolabs Introduces Polbase, an Information Repository of Scientific Data for Polymerase Researchers
Date:11/10/2011

IPSWICH, Mass., Nov. 10, 2011 /PRNewswire/ -- New England Biolabs (NEB), in its continuing commitment to open access science, announces Polbase, a new, free and open database covering DNA polymerase biochemistry, genetics and structural biology. Inspired by REBASE (the Restriction Enzyme Database, also developed and maintained by NEB), Polbase summarizes the information that exists in the extensive body of polymerase literature, making it easy for researchers to interrogate and use. Polbase can be accessed at http://polbase.neb.com.

(Logo: http://photos.prnewswire.com/prnh/20090921/NE79207LOGO-b)

Polymerases are responsible for the faithful replication of DNA and maintenance of genomic integrity via repair and recombination. In addition to their biological roles, polymerases with specialized features form the core of many biological techniques, including PCR, and DNA sequencing (Sanger and next generation). This family of enzymes is also finding increased utility in areas of more applied research, such as forensics and diagnostics. Despite their central biological function and growing importance to biotechnology, no single repository of polymerase information existed prior to Polbase.

"Polbase has been designed as a collaborative effort, with contributions from many experts in the various fields of polymerase research," states Dr. Bradley Langhorst, Postdoctoral Fellow at NEB. "We hope that the breadth of information that Polbase provides will enhance research and discovery for polymerase novices and experts alike."

Polbase was funded by a SBIR grant from the NIH (R44GM087021) and builds upon a number of public resources, including PubMed and the Protein Data Bank (PDB), without attempting to duplicate them. Polbase extends current resources with polymerase-centric features that are unavailable elsewhere and presents information in many new and dynamic ways.

About New England Biolabs

Established in the mid 1970's, New England Biolabs, Inc. is the industry leader in the discovery and production of enzymes for molecular biology applications and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR, gene expression, sample preparation for next generation sequencing, cellular analysis, epigenetics and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors. New England Biolabs is a privately held company, headquartered in Ipswich, MA and has extensive worldwide distribution through a network of exclusive distributors, agents and six subsidiaries located in Canada, China, France, Germany, Japan and the UK. For more information about New England Biolabs visit www.neb.com.


'/>"/>
SOURCE New England Biolabs
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. SwitchGear Genomics and New England Biolabs Develop New Multiplex Reporter Assay System
2. New England Research Institutes (NERI) Announces Additional $45M NIH Grant to Support the Pediatric Heart Network
3. New England Biolabs and Rubicon Genomics Enter into Distribution Agreement for Single Cell Amplification Products
4. Biotech Group Warns Proposed Medicare Cuts Could Hurt Critical Sector of New England Economy
5. Agreement Between SomaLogic and New England Biolabs Enables the Use of SOMAmer Technology for the Optimization of Multiple PCR Products
6. Comprendia and New England Biolabs Connect Epigenetics Scientists with New Social Media Application
7. New England Biolabs Opens New Subsidiary Office in France
8. TEI Biosciences Wins SBANE 2011 New England Innovation Award
9. TEI Biosciences Chairman, President and CEO Yiannis Monovoukas Named Ernst & Young Entrepreneur Of The Year® 2011 New England Award Semifinalist
10. New England Cord Blood Bank: Umbilical Cord Tissue Banking
11. Stryker Knee and Hip Implants Demonstrate Lowest Revision Rates, According to the National Joint Registry for England and Wales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2019)... ... November 06, 2019 , ... LeadingBiotech ... dialogue, today announces its East/West CEO conference to be held January ... , Kicking off the week of the J.P. Morgan Healthcare Conference and ...
(Date:11/5/2019)... TORONTO (PRWEB) , ... November 05, 2019 , ... ... cancer technology, announced it has received CE Mark for its Fusion Bx 2.0 ... semi-robotic arm and user-friendly interface, the Fusion Bx 2.0 will give urologists across ...
(Date:11/2/2019)... ... October 31, 2019 , ... A clinical trial ... each other: study managers, principal investigators, supply chain managers, manufacturers, IRT, CRAs and ... informed of the latest data, potentially leading to patient risk. , By having ...
(Date:11/2/2019)... ... 2019 , ... drug360 graph, a breakthrough knowledge graph product, ... tellic’s expertise in biomedical language processing and machine learning to bear on biomedical ... diseases, variants, phenotypes, and other biomedical entities. Researchers and analysts can use ...
Breaking Biology Technology:
(Date:11/9/2019)... (PRWEB) , ... November 08, 2019 , ... SiteSeer Technologies, ... Acquisitions as a new client and user of SiteSeer. The boutique real estate ... across the U.S. will use SiteSeer to supplement its own analysis of markets. ...
(Date:11/6/2019)... ... November 06, 2019 , ... ... MD, a senior pharmaceutical industry executive with expertise in clinical pharmacology and pharmacometrics ... and disease strategic data analytics, has joined the firm as an Expert Consultant. ...
(Date:11/5/2019)... ... November 05, 2019 , ... ... for drugs, biologics, gene therapies, and consumer health products, today announced it will ... Sofia, Barcelona, Spain on Nov. 12 – 14, 2019. , On Wednesday, Nov. ...
Breaking Biology News(10 mins):